Active Ingredient: ROFLUMILAST
Proprietary Name: ZORYVE
Dosage Form; Route of Administration: FOAM; TOPICAL
Strength: 0.3%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N217242
Product Number: 001
Approval Date: Dec 15, 2023
Applicant Holder Full Name: ARCUTIS BIOTHERAPEUTICS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
